Conclusions: the future of antimicrobial therapy - Augmentin® and beyond

International Journal of Antimicrobial Agents

Volumn 30, Issue SUPPL. 2, 2007, Pages 139-141

  Ball, Peter ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Amoxicillin clavulanate; Antibiotic resistance; History of medicine; Prescribing guidelines

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 36048938508     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.08.016     Document Type: Article

References (15)

1. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349 (1997) 1269-1276
2. Hoban D.J., Doern G.V., and Fluit A.C. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 32 (2001) S81-S93
3. Kohno S., Hoban D., and PROTEKT Surveillance Study Group. Comparing in vitro activity of telithromycin and β-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000). J Chemother 15 (2003) 335-341
4. Ball P., Baquero F., Cars O., et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 49 (2002) 31-40
5. Chang S.C., Chang H.J., and Lai M.S. Antibiotic usage in primary care units in Taiwan. Int J Antimicrob Agents 11 (1999) 23-30
6. Gilberg K., Laouri M., Wade S., and Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and under use of prescription drugs for asthma, depression and CHF. J Manag Care Pharm 9 (2003) 232-237
7. Udomthavornsuk B., Tatsanavivat P., Patjanasoontorn B., et al. Intervention of inappropriate antibiotic use at a university teaching hospital. J Med Assoc Thai 74 (1991) 429-436
8. Bronzwaer S.L., Cars O., Bucholz U., et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8 (2002) 278-282
9. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl. 2 (2007) S27-S72
10. Macfarlane J.T., Boswell T., Douglas G., et al. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56 Suppl. 4 (2001) iv1-iv64
11. Woodhead M., Blasi F., Ewig S., et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26 (2005) 1138-1180
12. Gleason P.P., Kapoor W.N., Stone R.A., et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society Guidelines for outpatients with community-acquired pneumonia. J Am Med Assoc 278 (1997) 1458-1465
13. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
14. Price D.B., Honeybourne D., Little P., et al. Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice. Respir Med 98 (2004) 17-24
15. Beilby J., Marley J., Walker D., Chamberlain N., Burke M., and FIESTA Study Group. Effect of changes in antibiotic prescribing on patient outcomes in a community setting: a natural experiment in Australia. Clin Infect Dis 34 (2002) 55-64